Deadline: 27-Aug-21
RTI is inviting proposals from local non-governmental organizations to conduct LF MDA Technical support in 2 municipalities of Bara District, Nepal.
Lymphatic Filariasis is a public health problem in Nepal. Based on the public health importance of lymphatic Filariasis, the World Health Organization (WHO) made a global call for its elimination by the year 2020 to which the Nepal Government has expressed its commitment.
Act to End Neglected Tropical Diseases | East is a five-year program funded by the United States Agency for International Development (USAID) that supports national governments to reach their control and elimination goals for neglected tropical diseases (NTDs) through proven, cost-effective public health interventions.
The Act to End NTDs | East program provides critical support to countries in their journey to self-reliance, helping them to create sustainable NTD programming within robust and resilient health systems.
Effective implementation of LF MDA by municipalities to increase coverage and compliance above required percentage and document learnings for possible replication.
Areas of Interest
Areas of interest for documentation include:
- Approaches to engage elected officials to support planning and participation in LF MDA
- Barriers/challenges in local ownership of planning and implementing LF MDA
- Successful approaches or opportunities to explore to provide additional support in planning and implementing LF MDA.
- Tools and resources that prove useful to municipalities in planning, implementing and monitoring LF MDA, like checklists for planning or supervision.
- Data or information requested by local actors to improve planning and implementing MDA
- Feedback from local municipalities on support provided by the public health officers
Additional Information
- The grant will be for the period from date of grant signed by both grantee and RTI to the date of approval of completed work by RTI.
- RTI intends to award one Fixed Amount Award (FAA). Payment will be made upon achieving stated milestones.
- No upfront payments will be made on commencement of the grant. There will be a total of five (5) milestones during project implementation, and each payment will be made based on satisfactory completion and acceptance by RTI of the stated deliverable(s) for that milestone.
- The selected organization will be required to adhere to local COVID-19 restrictions and regulations.
Results
In order to achieve the objective, Act to End NTDs | East focuses on reaching the following intermediate results:
- RESULT 1: Elimination of Lymphatic Filariasis, Trachoma, and Onchocerciasis in the Americas and where feasible in Africa
- RESULT 2: Sustainable National NTD Programs (National planning and financing progress)
- RESULT 3: Ensure continuous capacity to maintain and operate mass drug administration (MDA) and disease surveillance
For more information, visit https://www.rti.org/sites/default/files/rti_solicitation_act-east-rfp-fy22-po2.pdf
